NXGL
NEXGEL, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$0.27
+2.63%0
Insider buys (3m)
2
Insider sells (3m)
-$6.5K
Net value (3m)
-55.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 29, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | A-Award | 160,000 | $0.65 |
| Jun 23, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 6,000 | $0.59 |
| Jun 23, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 5,000 | $0.59 |
| Jun 15, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 3,000 | $0.61 |
| Jun 9, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 3,000 | $0.59 |
| Jun 3, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 2,000 | $0.59 |
| May 29, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 3,000 | $0.60 |
| May 29, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 7,000 | $0.61 |
| May 18, 2026 | Kieser Brian Joseph · director | Purchase | 833,334 | $0.80 |
| May 18, 2026 | Henry Scott Robert · director | Purchase | 20,834 | $0.80 |
| May 18, 2026 | Kieser Brian Joseph · director | Purchase | 1,666,667 | $0.60 |
| May 18, 2026 | Henry Scott Robert · director | Purchase | 41,667 | $0.60 |
| May 18, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Purchase | 50,000 | $0.80 |
| May 18, 2026 | Levy Adam R. · director, officer: Chief Executive Officer | Purchase | 100,000 | $0.60 |
| Dec 29, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 6,000 | $1.61 |
| Dec 29, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $1.57 |
| Nov 7, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $2.52 |
| Oct 6, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 1,600 | $2.50 |
| Oct 6, 2025 | Henry Scott Robert · director | Sale | 7,175 | $2.55 |
| Oct 6, 2025 | Henry Scott Robert · director | Sale | 825 | $2.50 |
| Oct 6, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 2,400 | $2.55 |
| Sep 29, 2025 | Henry Scott Robert · director | Sale | 7,697 | $2.36 |
| Aug 29, 2025 | Levy Adam R. · director, officer: Chief Executive Officer | Sale | 4,000 | $2.47 |
| Jun 27, 2025 | glassman steven mark · director | A-Award | 5,000 | $0.00 |
| Jun 27, 2025 | glassman steven mark · director | A-Award | 30,000 | $2.32 |
| Jun 27, 2025 | Henry Scott Robert · director | A-Award | 30,000 | $2.32 |
| Jun 27, 2025 | Henry Scott Robert · director | A-Award | 5,000 | $0.00 |
| Jun 27, 2025 | ZELDIS JEROME B · director | A-Award | 30,000 | $2.32 |
| Jun 27, 2025 | Stein John Nachum · director | A-Award | 30,000 | $2.32 |
| Jun 16, 2025 | Henry Scott Robert · director | Sale | 3,000 | $2.57 |
Institutional positioning
13F filings over the trailing two quarters
New 12Increased 8Reduced 4Sold out 5
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 128,536 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | 85,140 | Aug 14, 2026 |
| Virtu Financial LLC | New Position | 79,128 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 71,863 | Aug 12, 2026 |
| HRT FINANCIAL LP | Increased | 69,485 | Aug 14, 2026 |
| MORGAN STANLEY | Reduced | 54,980 | May 15, 2026 |
| MORGAN STANLEY | Unchanged | 54,980 | Aug 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 50,960 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Unchanged | 48,920 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 48,920 | May 15, 2026 |
| JANE STREET GROUP, LLC | Increased | 42,138 | May 12, 2026 |
| CITADEL ADVISORS LLC | New Position | 40,976 | Sep 2, 2026 |
| SIMON QUICK ADVISORS, LLC | Unchanged | 35,715 | May 6, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 34,040 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 34,040 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 29, 2026